Indical acquires Svanova from Boehringer Ingelheim

April 1, 2021

Indical has acquired the Svanova product portfolio from Boehringer Ingelheim. Through the acquisition, Indical becomes the exclusive provider of Svanova’s veterinary testing products, which include around 25 livestock ELISA assays.

Svanova arose out of the Swedish Veterinary Institute, a pioneer in veterinary diagnostic solutions for eradication programmes and disease monitoring. Initially, Svanova’s products were primarily used in Sweden. Since then, the company has expanded to meet the global demand for quality diagnostic solutions and today sells to 70+ countries.

Recent news

Fidelio becomes the new majority owner of Hemfrid…

Fidelio is excited about partnering with founder Monica Lindstedt, CEO Cecilia Tosting and the entire Hemfrid team on their continued growth journey. Since its foundation in 1996, Hemfrid has been a pioneer in an industry that makes everyday life easier.

Read more

First day of trading in Vimian’s shares on …

Vimian Group AB (publ) (“Vimian”, the “Group” or the “Company”), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, today announces the listing of and commencement

Read more

Vimian announces intention to list on Nasdaq Firs…

Vimian Group AB (publ), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, announces its intention to carry out a private placement of shares in the

Read more